secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001213900-25-025123
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics enters $100M ATM equity offering with Jefferies; terminates prior Cantor agreement
--------------------------------------------------------------------------------

- Company entered Open Market Sale Agreement with Jefferies LLC to sell up to $100M of common stock.
- Jefferies will receive 3.0% commission on gross sales price per share; issuer has no obligation to sell.
- Prior ATM agreement with Cantor Fitzgerald terminated effective March 14, 2025; no shares sold under it.
- Offering will be made under new S-3 registration statement filed March 19, 2025.
- No material penalties incurred from termination of Cantor agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/0001213900-25-025123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/ea0234885-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-025123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer